Found: 28
Select item for more details and to access through your institution.
Hacking Pancreatic Cancer: Present and Future of Personalized Medicine.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 7, p. 677, doi. 10.3390/ph14070677
- By:
- Publication type:
- Article
Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 7, p. 1547, doi. 10.3390/ijms18071547
- By:
- Publication type:
- Article
Can repeated surgical resection offer a chance of cure for recurrent cholangiocarcinoma?
- Published in:
- Langenbeck's Archives of Surgery, 2023, v. 408, n. 1, p. 1, doi. 10.1007/s00423-023-02839-y
- By:
- Publication type:
- Article
The (Eternal) Debate on Microwave Ablation Versus Radiofrequency Ablation in BCLC-A Hepatocellular Carcinoma.
- Published in:
- In Vivo, 2020, v. 34, n. 6, p. 3421, doi. 10.21873/invivo.12181
- By:
- Publication type:
- Article
How to Choose Between Percutaneous Transhepatic and Endoscopic Biliary Drainage in Malignant Obstructive Jaundice: An Updated Systematic Review and Meta-analysis.
- Published in:
- In Vivo, 2020, v. 34, n. 4, p. 1701, doi. 10.21873/invivo.11964
- By:
- Publication type:
- Article
Anti-EGFR Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-analysis.
- Published in:
- In Vivo, 2020, v. 34, n. 2, p. 479, doi. 10.21873/invivo.11798
- By:
- Publication type:
- Article
Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-27791-1
- By:
- Publication type:
- Article
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.559996
- By:
- Publication type:
- Article
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2429, doi. 10.3390/cancers14102429
- By:
- Publication type:
- Article
Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3256, doi. 10.3390/cancers12113256
- By:
- Publication type:
- Article
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster.
- Published in:
- BMC Medical Genetics, 2020, v. 21, n. 1, p. N.PAG, doi. 10.1186/s12881-020-01165-0
- By:
- Publication type:
- Article
Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.803133
- By:
- Publication type:
- Article
Role of MicroRNA in IPMN Lesions.
- Published in:
- JOP Journal of the Pancreas, 2017, v. 18, p. 181
- By:
- Publication type:
- Article
Role of MicroRNA in IPMN Lesions.
- Published in:
- JOP Journal of the Pancreas, 2017, v. 18, p. 181
- By:
- Publication type:
- Article
Decreasing Albumin mRNA Expression in Cholangiocarcinomas along the Bile Duct Tree.
- Published in:
- Pathobiology, 2024, v. 91, n. 5, p. 338, doi. 10.1159/000538706
- By:
- Publication type:
- Article
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 10, p. 1317, doi. 10.1080/0284186X.2021.1953704
- By:
- Publication type:
- Article
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients.
- Published in:
- Oncology, 2018, v. 94, n. 1, p. 7, doi. 10.1159/000479929
- By:
- Publication type:
- Article
Is post‐transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases?
- Published in:
- Cancer Communications, 2020, v. 40, n. 9, p. 461, doi. 10.1002/cac2.12072
- By:
- Publication type:
- Article
In Reply.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients.
- Published in:
- Oncologist, 2016, v. 21, n. 5, p. 600, doi. 10.1634/theoncologist.2015-0356
- By:
- Publication type:
- Article
Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1137510
- By:
- Publication type:
- Article
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study.
- Published in:
- Medicina (1010660X), 2022, v. 58, n. 11, p. 1543, doi. 10.3390/medicina58111543
- By:
- Publication type:
- Article
Improvements in Systemic Therapies for Advanced Malignant Mesothelioma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10415, doi. 10.3390/ijms241310415
- By:
- Publication type:
- Article
Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2020, v. 27, n. 1, p. 1, doi. 10.1177/1073274820983013
- By:
- Publication type:
- Article
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-52991-8
- By:
- Publication type:
- Article
The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma.
- Published in:
- Current Oncology, 2023, v. 30, n. 5, p. 4754, doi. 10.3390/curroncol30050358
- By:
- Publication type:
- Article
Intensive Follow-Up Program and Oncological Outcomes of Biliary Tract Cancer Patients after Curative-Intent Surgery: A Twenty-Year Experience in a Single Tertiary Medical Center.
- Published in:
- Current Oncology, 2022, v. 29, n. 7, p. 5084, doi. 10.3390/curroncol29070402
- By:
- Publication type:
- Article